| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edbb950ac0ac78399da9b0e728e971e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-002 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J51-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate |
2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68cb9fa1602ceba6b2c5e9bdce1f925c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11f8067739f8e42b27fe45e742499224 |
| publicationDate |
2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015081170-A2 |
| titleOfInvention |
Ganaxolone derivatives for treatment of central nervous systems disorders |
| abstract |
The present invention is directed to Ganaxolone prodrugs with increased aqueous solubility and oral bioavailability relative to Ganaxolone and that enable development of stable extended release formulations which offer a significant therapeutic advantage and improved patience compliance by enabling treatments with lower doses over prolonged periods of time. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10780099-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266662-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021027744-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022166774-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639317-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000531-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021098872-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019211668-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112823164-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071740-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023178299-A1 |
| priorityDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |